Clinical Trials Browser

Pancreatic Intraductal Neoplasms, Carcinoma, Acinar Cell, Cholangiocarcinoma

NCT07213791 2026-05-22

FiREBOLT

Pancreatic Intraductal Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT04622423 2026-04-06

LiMeT

Recruiting

625 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Colorectal Neoplasms

NCT07463872 2026-03-11

Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data

Recruiting

500 enrolled

EndocrineGastrointestinalNET

Pancreatic Intraductal Neoplasms, Pancreatic Pseudocyst, Cystadenoma, Serous, Neuroendocrine Tumors

NCT07439757 2026-02-27

AI-Powered Precision Decision-Making for Pancreatic Diseases

Recruiting

2,000 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Adenoma, Islet Cell, Pancreatic Neoplasms, Pancreatitis, Pancreatitis, Chronic

NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Phase 3 Completed

546 enrolled 29 charts

Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT07262957 2025-12-22

PANENCA

Phase 4 Recruiting

400 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Duodenal Neoplasms, Fistula, Pancreatitis

NCT06694792 2025-11-19

INCITE

Recruiting

800 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Diseases

NCT06519097 2025-11-13

Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

Phase 2 Active not recruiting

4 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT04291651 2025-09-18

UCSF PCR

Recruiting

4,000 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Mucocele, Pancreatic Cyst, Pancreatic Diseases, Pancreatic Neoplasms, Cystadenoma, Serous

NCT06574373 2025-09-03

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

Recruiting

3,600 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT02070705 2025-07-31

DCE MRI in Patients With Pancreatic Cancer

Phase NA Terminated

77 enrolled

Gastrointestinal

Pancreatic carcinoma, familial, Pancreatic Intraductal Neoplasms

NCT04207944 2025-06-15

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Phase 2 Active not recruiting

100 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT07014709 2025-06-11

IPMN-GLP1RA

Not yet recruiting

30 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT06948474 2025-04-29

Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery

Phase NA Active not recruiting

45 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT06162468 2025-04-23

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

Phase NA Not yet recruiting

20 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT03711890 2025-03-30

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

Phase NA Suspended

75 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT06276764 2025-03-07

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Enrolling by invitation

500 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Cyst, Pancreatic Neoplasms

NCT06706700 2024-11-26

EMI-IPMN

Recruiting

586 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Cyst

NCT06283576 2024-04-24

PANCAID

Enrolling by invitation

200 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Diabetes Mellitus, Pancreatic Neoplasms, Smoking, Pancreatitis, Chronic

NCT05117723 2024-04-18

MAPS

Recruiting

1,000 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Cyst

NCT05914077 2023-09-18

RESCUE

Phase 3 Unknown

140 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT05593393 2022-11-14

A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm

Unknown

1,500 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT01643460 2022-04-14

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

Phase NA Completed

33 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Neoplasms, Pancreatic Cyst, Cystadenocarcinoma, Mucinous, Cystadenoma, Mucinous

NCT05095831 2022-01-04

EUS Shear Wave for Solid Pancreatic Lesions.

Unknown

25 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Autoimmune Pancreatitis, Pancreatitis, Acute Hemorrhagic, Pancreatic Neoplasms, Pancreatitis, Pancreatitis, Acute Necrotizing, Pancreatitis, Alcoholic, Carcinoma, Pancreatic Ductal, Pancreatitis, Chronic

NCT03884179 2019-03-21

Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

Unknown

58 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Pseudocyst, Somatostatinoma

NCT00985777 2016-03-01

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Phase 1 Completed

26 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2 Terminated

6 enrolled 8 charts

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

Clinical Trials

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

FiREBOLT

LiMeT

Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data

AI-Powered Precision Decision-Making for Pancreatic Diseases

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

PANENCA

INCITE

Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

UCSF PCR

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

DCE MRI in Patients With Pancreatic Cancer

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

IPMN-GLP1RA

Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

EMI-IPMN

PANCAID

MAPS

RESCUE

A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

EUS Shear Wave for Solid Pancreatic Lesions.

Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery